David L. Eisenbrandt

405 total citations
15 papers, 265 citations indexed

About

David L. Eisenbrandt is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis. According to data from OpenAlex, David L. Eisenbrandt has authored 15 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in David L. Eisenbrandt's work include Effects and risks of endocrine disrupting chemicals (3 papers), Immunotoxicology and immune responses (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). David L. Eisenbrandt is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (3 papers), Immunotoxicology and immune responses (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). David L. Eisenbrandt collaborates with scholars based in United States, Netherlands and Italy. David L. Eisenbrandt's co-authors include Joel L. Mattsson, Ralph R. Albee, Matthew J. LeBaron, Robert D. Phemister, Reza J. Rasoulpour, B. Bhaskar Gollapudi, Joseph Smith, Lynn H. Pottenger, Sabitha Papineni and Susan L. Makris and has published in prestigious journals such as Toxicological Sciences, Critical Reviews in Toxicology and Journal of the American Veterinary Medical Association.

In The Last Decade

David L. Eisenbrandt

15 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Eisenbrandt United States 10 114 71 63 42 38 15 265
Nathalie Delrue France 7 111 1.0× 76 1.1× 62 1.0× 20 0.5× 42 1.1× 7 281
Jyotigna Mehta United Kingdom 10 53 0.5× 43 0.6× 65 1.0× 21 0.5× 60 1.6× 17 246
Todd J. Zurlinden United States 12 105 0.9× 30 0.4× 36 0.6× 32 0.8× 12 0.3× 22 387
William H. Steinhagen United States 17 238 2.1× 209 2.9× 44 0.7× 37 0.9× 42 1.1× 20 483
Markus Frericks Germany 10 116 1.0× 48 0.7× 20 0.3× 104 2.5× 24 0.6× 23 336
R. Roll Germany 8 63 0.6× 92 1.3× 28 0.4× 11 0.3× 97 2.6× 18 324
Bertrand Desprez France 10 101 0.9× 19 0.3× 149 2.4× 22 0.5× 43 1.1× 13 297
Daniel R. Hallinger United States 12 175 1.5× 30 0.4× 31 0.5× 52 1.2× 21 0.6× 17 548
Brenda Carver United States 12 157 1.4× 78 1.1× 13 0.2× 9 0.2× 77 2.0× 15 337
AKIYOSHI YOSHIDA Japan 10 49 0.4× 42 0.6× 18 0.3× 42 1.0× 52 1.4× 32 325

Countries citing papers authored by David L. Eisenbrandt

Since Specialization
Citations

This map shows the geographic impact of David L. Eisenbrandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Eisenbrandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Eisenbrandt more than expected).

Fields of papers citing papers by David L. Eisenbrandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Eisenbrandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Eisenbrandt. The network helps show where David L. Eisenbrandt may publish in the future.

Co-authorship network of co-authors of David L. Eisenbrandt

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Eisenbrandt. A scholar is included among the top collaborators of David L. Eisenbrandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Eisenbrandt. David L. Eisenbrandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
LaRocca, Jessica, Reza J. Rasoulpour, B. Bhaskar Gollapudi, et al.. (2017). Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor. Toxicology Reports. 4. 586–597. 12 indexed citations
2.
Hannas, Bethany R., Robert G. Ellis‐Hutchings, Claire Terry, et al.. (2016). Dietary Route of Exposure for Rabbit Developmental Toxicity Studies. Toxicological Sciences. 154(1). 90–100. 4 indexed citations
3.
Rasoulpour, Reza J., M. Sue Marty, Fagen Zhang, et al.. (2015). Pronamide: Human relevance of liver-mediated rat leydig cell tumors. Regulatory Toxicology and Pharmacology. 72(2). 394–404. 8 indexed citations
4.
Papineni, Sabitha, M. Sue Marty, Reza J. Rasoulpour, et al.. (2015). Mode of action and human relevance of pronamide-induced rat thyroid tumors. Regulatory Toxicology and Pharmacology. 71(3). 541–551. 17 indexed citations
5.
Marty, M. Sue, Sabitha Papineni, Katherine K. Coady, et al.. (2015). Pronamide: Weight of evidence for potential estrogen, androgen or thyroid effects. Regulatory Toxicology and Pharmacology. 72(2). 405–422. 8 indexed citations
6.
LeBaron, Matthew J., Reza J. Rasoulpour, B. Bhaskar Gollapudi, et al.. (2014). Characterization of Nuclear Receptor-Mediated Murine Hepatocarcinogenesis of the Herbicide Pronamide and Its Human Relevance. Toxicological Sciences. 142(1). 74–92. 18 indexed citations
7.
Stagg, Nicola J., Matthew J. LeBaron, David L. Eisenbrandt, B. Bhaskar Gollapudi, & James E. Klaunig. (2012). Assessment of Possible Carcinogenicity of Oxyfluorfen to Humans Using Mode of Action Analysis of Rodent Liver Effects. Toxicological Sciences. 128(2). 334–345. 23 indexed citations
8.
Cooper, Ralph L., James C. Lamb, Sue Barlow, et al.. (2006). A Tiered Approach to Life Stages Testing for Agricultural Chemical Safety Assessment. Critical Reviews in Toxicology. 36(1). 69–98. 94 indexed citations
9.
Mattsson, Joel L., David L. Eisenbrandt, & Ralph R. Albee. (1990). Screening for Neurotoxicity: Complementarity of Functional and Morphologic Techniques. Toxicologic Pathology. 18(1_part_2). 115–127. 11 indexed citations
10.
Eisenbrandt, David L., Joel L. Mattsson, Ralph R. Albee, P.J. Spencer, & Keith A. Johnson. (1990). Spontaneous Lesions in Subchronic Neurotoxicity Testing of Rats. Toxicologic Pathology. 18(1_part_2). 154–164. 18 indexed citations
11.
Mattsson, Joel L., Ralph R. Albee, David L. Eisenbrandt, & Louis W. Chang. (1988). Subchronic neurotoxicity in rats of the structural fumigant, sulfuryl fluoride. Neurotoxicology and Teratology. 10(2). 127–133. 19 indexed citations
12.
Eisenbrandt, David L. & Robert D. Phemister. (1980). Counting renal corpuscles in tissue sections. Virchows Archiv B Cell Pathology Including Molecular Pathology. 32(1). 177–184. 1 indexed citations
13.
Eisenbrandt, David L. & Robert D. Phemister. (1979). Postnatal development of the canine kidney: Quantitative and qualitative morphology. American Journal of Anatomy. 154(2). 179–193. 18 indexed citations
14.
Eisenbrandt, David L. & Joseph Smith. (1973). Evaluation of Preservatives and Containers for Storage of Canine Blood. Journal of the American Veterinary Medical Association. 163(8). 988–990. 5 indexed citations
15.
Eisenbrandt, David L. & Joseph Smith. (1973). Use of Biochemical Measures to Estimate Viability of Red Blood Cells in Canine Blood Stored in Acid Citrate Dextrose Solution, With and Without Added Ascorbic Acid. Journal of the American Veterinary Medical Association. 163(8). 984–987. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026